Cerenovus, a subsidiary of Johnson & Johnson Medical Devices, is a leading innovator in the neurovascular industry, headquartered in the United States. Founded with a commitment to advancing patient care, Cerenovus focuses on developing cutting-edge solutions for the treatment of stroke and other neurovascular conditions. With a strong presence in major operational regions across North America and Europe, the company offers a range of unique products, including advanced thrombectomy devices and innovative embolisation solutions. Cerenovus is recognised for its dedication to improving clinical outcomes, positioning itself as a trusted partner for healthcare professionals. Since its inception, Cerenovus has achieved significant milestones, solidifying its reputation in the market through a combination of technological innovation and a patient-centric approach.
We don't have data for Cerenovus, but we can show you information about their parent organization instead.
View parent company